Farther Finance Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $671K | Sell |
5,305
-852
| -14% | -$108K | 0.01% | 762 |
|
|
2025
Q1 | $766K | Sell |
6,157
-276
| -4% | -$34.3K | 0.02% | 613 |
|
|
2024
Q4 | $850K | Buy |
6,433
+663
| +11% | +$87.7K | 0.03% | 414 |
|
|
2024
Q3 | $840K | Buy |
5,770
+2,264
| +65% | +$330K | 0.03% | 402 |
|
|
2024
Q2 | $480K | Buy |
3,506
+163
| +5% | +$22.3K | 0.02% | 492 |
|
|
2024
Q1 | $457K | Buy |
3,343
+2,236
| +202% | +$306K | 0.03% | 420 |
|
|
2023
Q4 | $150K | Buy |
1,107
+70
| +7% | +$9.51K | 0.01% | 650 |
|
|
2023
Q3 | $127K | Buy |
1,037
+554
| +115% | +$67.8K | 0.02% | 489 |
|
|
2023
Q2 | $61.3K | Sell |
483
-1,085
| -69% | -$138K | 0.01% | 600 |
|
|
2023
Q1 | $203K | Buy |
1,568
+1,300
| +485% | +$168K | 0.06% | 260 |
|
|
2022
Q4 | $35.2K | Buy |
+268
| New | +$35.2K | 0.01% | 576 |
|